These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 26080090)

  • 1. The positive effect on ketamine as a priming adjuvant in antidepressant treatment.
    Melo A; Kokras N; Dalla C; Ferreira C; Ventura-Silva AP; Sousa N; Pêgo JM
    Transl Psychiatry; 2015 May; 5(5):e573. PubMed ID: 26080090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ketamine plus imipramine treatment induces antidepressant-like behavior and increases CREB and BDNF protein levels and PKA and PKC phosphorylation in rat brain.
    Réus GZ; Stringari RB; Ribeiro KF; Ferraro AK; Vitto MF; Cesconetto P; Souza CT; Quevedo J
    Behav Brain Res; 2011 Aug; 221(1):166-71. PubMed ID: 21397634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Nitric Oxide in the Antidepressant Actions of 5-Aminoimidazole-4-Carboxamide-1-β-D-Ribofuranoside in Insulin-Resistant Mice.
    Liu W; Wang Y; Li H; Ji L
    Psychosom Med; 2016 Jan; 78(1):102-12. PubMed ID: 26569535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex differences in the rapid and the sustained antidepressant-like effects of ketamine in stress-naïve and "depressed" mice exposed to chronic mild stress.
    Franceschelli A; Sens J; Herchick S; Thelen C; Pitychoutis PM
    Neuroscience; 2015 Apr; 290():49-60. PubMed ID: 25595985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring a post-traumatic stress disorder paradigm in Flinders sensitive line rats to model treatment-resistant depression II: response to antidepressant augmentation strategies.
    Brand SJ; Harvey BH
    Acta Neuropsychiatr; 2017 Aug; 29(4):207-221. PubMed ID: 27692010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ketamine and imipramine in the nucleus accumbens regulate histone deacetylation induced by maternal deprivation and are critical for associated behaviors.
    Réus GZ; Abelaira HM; dos Santos MA; Carlessi AS; Tomaz DB; Neotti MV; Liranço JL; Gubert C; Barth M; Kapczinski F; Quevedo J
    Behav Brain Res; 2013 Nov; 256():451-6. PubMed ID: 24004850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the excitation:inhibition functional balance in the mPFC in the onset of antidepressants.
    Yin YY; Wang YH; Liu WG; Yao JQ; Yuan J; Li ZH; Ran YH; Zhang LM; Li YF
    Neuropharmacology; 2021 Jun; 191():108573. PubMed ID: 33945826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of mTOR in depression and antidepressant responses.
    Abelaira HM; Réus GZ; Neotti MV; Quevedo J
    Life Sci; 2014 Apr; 101(1-2):10-4. PubMed ID: 24582593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mood stabilizer lithium potentiates the antidepressant-like effects and ameliorates oxidative stress induced by acute ketamine in a mouse model of stress.
    Chiu CT; Scheuing L; Liu G; Liao HM; Linares GR; Lin D; Chuang DM
    Int J Neuropsychopharmacol; 2014 Dec; 18(6):. PubMed ID: 25548109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anxiolytic- and antidepressant-like properties of ketamine in behavioral and neurophysiological animal models.
    Engin E; Treit D; Dickson CT
    Neuroscience; 2009 Jun; 161(2):359-69. PubMed ID: 19321151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketamine and rapid-acting antidepressants: a window into a new neurobiology for mood disorder therapeutics.
    Abdallah CG; Sanacora G; Duman RS; Krystal JH
    Annu Rev Med; 2015; 66():509-23. PubMed ID: 25341010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Burst-firing patterns in the prefrontal cortex underlying the neuronal mechanisms of depression probed by antidepressants.
    Guo F; Zhang Q; Zhang B; Fu Z; Wu B; Huang C; Li Y
    Eur J Neurosci; 2014 Nov; 40(10):3538-47. PubMed ID: 25209309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adult hippocampal neuroplasticity triggers susceptibility to recurrent depression.
    Alves ND; Correia JS; Patrício P; Mateus-Pinheiro A; Machado-Santos AR; Loureiro-Campos E; Morais M; Bessa JM; Sousa N; Pinto L
    Transl Psychiatry; 2017 Mar; 7(3):e1058. PubMed ID: 28291258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute treatment with ketamine and chronic treatment with minocycline exert antidepressant-like effects and antioxidant properties in rats subjected different stressful events.
    Maciel AL; Abelaira HM; de Moura AB; de Souza TG; Rosa T; Matos D; Tuon T; Garbossa L; Strassi AP; Fileti ME; Goldim MP; Mathias K; Petronilho F; Quevedo J; Réus GZ
    Brain Res Bull; 2018 Mar; 137():204-216. PubMed ID: 29253605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the effectiveness of chronic antidepressant drug treatments in the hippocampal mitochondria - A proteomic study in an animal model of depression.
    Głombik K; Stachowicz A; Trojan E; Olszanecki R; Ślusarczyk J; Suski M; Chamera K; Budziszewska B; Lasoń W; Basta-Kaim A
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Aug; 78():51-60. PubMed ID: 28526399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated ketamine administration redeems the time lag for citalopram's antidepressant-like effects.
    Zhang GF; Liu WX; Qiu LL; Guo J; Wang XM; Sun HL; Yang JJ; Zhou ZQ
    Eur Psychiatry; 2015 Jun; 30(4):504-10. PubMed ID: 25795441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in amino acid levels in mouse brain regions after adjunctive treatment of brexpiprazole with fluoxetine: comparison with (R)-ketamine.
    Ma M; Ren Q; Fujita Y; Yang C; Dong C; Ohgi Y; Futamura T; Hashimoto K
    Psychopharmacology (Berl); 2017 Nov; 234(21):3165-3173. PubMed ID: 28748374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral, endocrine, and neuronal alterations in zebrafish (Danio rerio) following sub-chronic coadministration of fluoxetine and ketamine.
    Pittman J; Hylton A
    Pharmacol Biochem Behav; 2015 Dec; 139 Pt B():158-62. PubMed ID: 26303305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VGF and its C-terminal peptide TLQP-62 in ventromedial prefrontal cortex regulate depression-related behaviors and the response to ketamine.
    Jiang C; Lin WJ; Labonté B; Tamminga CA; Turecki G; Nestler EJ; Russo SJ; Salton SR
    Neuropsychopharmacology; 2019 Apr; 44(5):971-981. PubMed ID: 30504797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two cellular hypotheses explaining the initiation of ketamine's antidepressant actions: Direct inhibition and disinhibition.
    Miller OH; Moran JT; Hall BJ
    Neuropharmacology; 2016 Jan; 100():17-26. PubMed ID: 26211972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.